Home/Filings/4/0001104659-19-075206
4//SEC Filing

Aradhye Shreeram 4

Accession 0001104659-19-075206

CIK 0001633070other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 8:03 PM ET

Size

7.9 KB

Accession

0001104659-19-075206

Insider Transaction Report

Form 4
Period: 2019-12-18
Aradhye Shreeram
EVP & Chief Developmnt Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-12-18+54,50054,500 total
    Exercise: $3.40Exp: 2029-12-18Common Stock (54,500 underlying)
  • Award

    Restricted Stock Units

    2019-12-18+66,80166,801 total
    Common Stock (66,801 underlying)
Footnotes (3)
  • [F1]25% of this option shall vest and become exercisable on December 18, 2020, with the remainder to vest in 12 equal quarterly installments thereafter.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of AXLA common stock.
  • [F3]The restricted stock units vest as follows: 1/3 of the grant shall vest on December 18, 2021; and the remaining 2/3 of the grant shall vest on December 18, 2022.

Documents

1 file

Issuer

Axcella Health Inc.

CIK 0001633070

Entity typeother

Related Parties

1
  • filerCIK 0001778372

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 8:03 PM ET
Size
7.9 KB